Skip to content
ArgusBio

Provider profile

Rentschler Biopharma.

Biologics CDMOs

Rentschler Biopharma describes cell line development, process, analytical and formulation development, and cGMP drug substance manufacturing of recombinant proteins and monoclonal antibodies for clinical and commercial supply. It lists headquarters and manufacturing in Laupheim, Germany, and a manufacturing site in Milford, MA, USA with single-use bioreactors.

Website
rentschler-biopharma.com (opens in a new tab)
Sources reviewed
November 4, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Analytical development and QC testing3
  • Cell line development2
  • Formulation development6
  • GMP drug substance manufacturing4Stated for the Velocity fast-track offering (released drug substance for Phase I/II projects)
  • Process development1,2
  • Technology transfer2

Platforms and methods

  • Mammalian cell culture2Stated as a track-record line on the process development page
  • Single-use bioreactors7Stated for the new manufacturing line at Milford, MA

Drug substance / drug product

  • Drug substance2,4Evidence cites released drug substance for Phase I/II clinical projects (Velocity offering)

Development experience

Development experience

Development stage

  • Commercial7,8Stated for Milford, MA; the Laupheim page also lists cGMP production for clinical and commercial supply
  • Phase 14Stated for the Velocity fast-track drug substance offering (Phase I/II)

Modality

  • Monoclonal antibodies3,4
  • Recombinant proteins2,3

Locations

Locations

  • Laupheim, Germany · Headquarters9
  • Laupheim, Germany · Manufacturing site8,9
  • Milford, United States · Manufacturing site7

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • GMP / cGMP3,5

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Available capacity, slot timing and scale for your next campaign
  • Recent experience with your specific modality and expression system or chemistry
  • Regulatory inspection history of the specific site that would manufacture your product
  • Technology-transfer approach, timeline and who owns the resulting process knowledge
  • Analytical and QC release testing done in-house versus subcontracted
  • Quality agreement terms, batch-failure responsibility and change-order mechanics

Choosing a CDMO: a practical guide

Evidence and sources

Evidence and sources

  1. 1Serviceportfolio (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Process Development (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3GMP Manufacturing Services (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4Rentschler Development Services - Velocity (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Analytical Development (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Formulation Development Services (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Rentschler Biopharma in Milford (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  8. 8Rentschler Biopharma in Laupheim (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  9. 9About Us (opens in a new tab)Rentschler Biopharma · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other biologics cdmos providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.